CochLear (OTCMKTS:CHEOY) Shares Up 3.5% – Here’s What Happened

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) shot up 3.5% during mid-day trading on Monday. The stock traded as high as $51.67 and last traded at $51.67. 2,112 shares were traded during mid-day trading, a decline of 96% from the average session volume of 51,690 shares. The stock had previously closed at $49.9032.

Wall Street Analyst Weigh In

CHEOY has been the subject of a number of research reports. Canaccord Genuity Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Jefferies Financial Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Finally, Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target for the company. in a research report on Thursday, July 16th. Five equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $117.00.

CochLear Stock Up 2.3%

The company has a 50 day moving average of $46.51 and a two-hundred day moving average of $45.73.

About CochLear

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids.

The company’s portfolio includes cochlear implants, bone conduction hearing implants, and related sound processors, accessories, software and support services. Cochlear also provides rehabilitation resources, clinical support and ongoing product services intended to help recipients use and maintain their hearing systems.

Founded in 1981 and headquartered in Sydney, Australia, Cochlear serves customers through a global network spanning Australia, New Zealand, North America, Europe, Asia and other international markets.